Cited by Crossref (5)

  1. Amit Guy, Abed N. Azab, Idit F. Liberty, Zaid Afawi, Ali Alhoashla, Muhammad Abu Tailakh. Adherence to liraglutide among individuals with overweight and obesity: Patient characteristics and clinical measures. Diabetes Obesity Metabolism 2024;26:1346
    https://doi.org/10.1111/dom.15436
  2. Ji-Eun Song, Hae-Jin Ko, A-Sol Kim. Comparison of the Efficacy of Anti-Obesity Medications in Real-World Practice. DDDT 2024;Volume 18:845
    https://doi.org/10.2147/DDDT.S445415
  3. Hiroshi Bando. Clinically Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) with Related Factors. Asp Biomed Clin Case Rep 2024;7:201
    https://doi.org/10.36502/2024/ASJBCCR.6363
  4. Amin Ariaee, Malinda Salim, Ben J. Boyd, Clive Prestidge, Paul Joyce. Montmorillonite restricts free fatty acid liberation and alters self-assembled structures formed during in vitro lipid digestion. Journal of Colloid and Interface Science 2024;675:660
    https://doi.org/10.1016/j.jcis.2024.07.042
  5. Marija Jovanović, Milena Kovačević, Milica Ćulafić. Role of pharmacists in the management of patients with obesity. Arhiv za farmaciju 2024;74:483
    https://doi.org/10.5937/arhfarm74-50561